Scribd
Upload
112 views2 pages

Bharat Biotech

Uploaded by

Madhukar Saxena
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
112 views2 pages

Bharat Biotech

Uploaded by

Madhukar Saxena
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 2

Profile of an Indian Company

Bharat Biotech International Limited


Bharat Biotech International Limited is an Indian private biotechnology company headquartered in Hyderabad,
India engaged in the drug discovery, drug development, and manufacture of vaccines, bio-therapeutics,
pharmaceuticals and health care products.

The company was founded in


1996 by Dr. Krishna M. Ella
(Chairman
Leading the & fightMD),
against Diseases
Headquartered at Genome
“At Bharat Biotech, we do not see ourselves combating competitors; instead we are combating again
Valley,
Dr. Krishna M. Ella, Chairman & MD,
Turakapally,Hyderabad with
Bharat Biotech International Limited.
products range from vaccines
like ROTAVAC, Typbar
TCV, Biopolio, Comvac,
JENVAC and COVAXIN. The company has been responsible for developing an
eco-friendly and a naturally strain derived Rotavirus
vaccine called ROTAVAC.
TWO DECADES OF INNOVATION
They were first to develop vaccines for viral diseases
For 20 years, the company has been like Chikungunya and Zika. The company also
creating innovative vaccines and produces vaccines for Japanese Encephalitis.
bio-therapeutics that help patients
around the world lead healthier lives. AT THE CUTTING-EDGE OF SCIENCE

As a research-led company, it has successfully


pursued scientific breakthroughs that help
patients overcome challenging diseases.

Development of COVID-19 Vaccine


BBV152 (known as COVAXIN)
 In April 2020, the company partnered with US-based company FluGen and University of Wisconsin-
Madison to develop a COVID-19 vaccine.
 In May 2020, Indian Council of Medical Research's (ICMR's) National Institute of Virology approved and
provided the virus strains for developing a fully indigenous COVID-19 vaccine.
 On June 29, 2020, the company got permission to conduct Phase 1 and Phase 2 clinical trials in India for
COVID-19 vaccine Covaxin, from Drugs Controller General of India (DCGI).
 The Central Drugs Laboratory (CDL) at Kasauli in Himachal Pradesh has been engaged in testing experimental
batches of Bharat Biotech's COVID-19 vaccine Covaxin on a priority basis.
 A total of 12 sites were selected by the Indian Council for Medical Research for Phase I and II randomised,
double-blind and placebo-controlled clinical trials of vaccine candidate.
 In September 2020, the company announced that it was
 In December 2020, the company announced going to manufacture the novel chimp-adenovirus, a
the report for Phase I trials and presented the single dose intranasal vaccine for COVID-19 being
results through medRxiv preprint; the report developed in collaboration with the Washington
was later published in the “The Lancet”. University School of Medicine in St Louis, Missouri.
 In November 2020, Covaxin received the approval to
conduct Phase III human trials. The trial involves a randomised, double-blinded, placebo-controlled study
among volunteers of age group 18 and above. It covered a total of 22 sites consisting several states, including
Delhi, Karnataka and West Bengal.

 COVAXIN has been granted approval for emergency use in India by DCGI-CDSCO on Jan 03, 2021.
 Global Acceptance of COVAXIN®:
 Bharat biotech has been approached by several countries for the procurement of COVAXIN.
 Supplies from government to government in the following countries takes place:Mongolia, Myanmar,
Sri Lanka, Philippines, Bahrain, Oman, Maldives and Mauritius.

To complete

 Approval and Commissioning


 News cuttings
 Summary with company standings
 Size & Spacing and finishing A person holding a vial of the Covaxin vaccine

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy